Advisory Alpha’s Idexx Laboratories IDXX Stock Holding History

Advisory Alpha’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-331	Closed	-$224K	–	556
2025 Q4	$224K	Sell	331 -34	-9%	-$23.2K	0.01%	476
2025 Q3	$231K	Buy	+365	New	+$222K	0.01%	475
2020 Q2	–	Sell	-5	Closed	-$1.34K	–	322
2020 Q1	$1.34K	Buy	+5	New	+$1.3K	﹤0.01%	622
2019 Q4	–	Sell	-9	Closed	-$2.45K	–	838
2019 Q3	$2.45K	Buy	+9	New	+$2.5K	﹤0.01%	625
2019 Q2	–	Sell	-3	Closed	-$739	–	356
2019 Q1	$739	Buy	+3	New	+$619	﹤0.01%	617

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Advisory Alpha's IDXX Position: Q1 2026 in Review

Advisory Alpha sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 331 shares — an estimated $224K sold.

Advisory Alpha first reported a position in IDXX in Q1 2019 and held it in 5 quarters. The position peaked at $231K in Q3 2025. 1,316 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Advisory Alpha reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
Advisory Alpha sold 331 Idexx Laboratories shares in Q1 2026, an estimated $224K.
Advisory Alpha first reported a position in Idexx Laboratories in Q1 2019 and held it in 5 quarters.
Advisory Alpha's Idexx Laboratories position peaked at $231K in Q3 2025.
1,316 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Advisory Alpha's 13F filing for Q1 2026, filed 14 May 2026.